Close
Close

Spinal Muscular Atrophy (SMA) is the leading genetic cause of death in infants and toddlers and is associated with a high rate of childhood mortality in its most severe forms. In a collaboration between Roche Pharma Research and Early Development (pRED), PTC Pharmaceuticals and the SMA Foundation, orally available molecules were discovered that may specifically correct a certain genetic defect in this devastating disorder. In mouse models of SMA, the compounds allow the animals to survive, grow and develop a normal neuromuscular system. We are working together to make a difference for SMA patients and their families.
For more information: www.roche.com

More Videos from Roche on http://www.youtube.com/user/roche

by Abidemi Uruejoma
86 views 1 month ago
by Abidemi Uruejoma
93 views 2 months ago
by Abidemi Uruejoma
89 views 2 months ago
3.08333333333
3.1 from 12 votes
Free Newsletter
Find a Clinical Trial
Related Videos
by Abidemi Uruejoma
154 views
by Abidemi Uruejoma
909 views
by Abidemi Uruejoma
7,231 views